Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acetazolamide and high altitude diseases.

A R Bradwell1, A D Wright, M Winterborn

  • 1Department of Immunology, Medical School, University of Birmingham, England.

International Journal of Sports Medicine
|October 1, 1992
PubMed
Summary

Acetazolamide effectively prevents acute mountain sickness symptoms like headache and nausea. While beneficial for mild cases, its efficacy for severe conditions and in combination therapies requires further investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of nicotinic acid supplementation on digestion, metabolism, microbiome, and production in late-lactation Holstein cows.

Journal of dairy science·2024
Same author

Healthcare staff perceptions and misconceptions regarding antibody testing in the United Kingdom: implications for the next steps for antibody screening.

The Journal of hospital infection·2020
Same author

Acetazolamide can impair exercise performance; it depends upon the cohort studied.

Journal of applied physiology (Bethesda, Md. : 1985)·2020
Same author

Experience from the selection and nutritional preparation for Expedition ICE MAIDEN: the first successful all-female unassisted Antarctic traverse.

BMJ military health·2019
Same author

Advances in the available non-biological pharmacotherapy prevention and treatment of acute mountain sickness and high altitude cerebral and pulmonary oedema.

Expert opinion on pharmacotherapy·2018
Same author

Sub-concussive trauma, acute concussion, and history of multiple concussions: Effects on quiet stance postural control stability.

International journal of psychophysiology : official journal of the International Organization of Psychophysiology·2018

Area of Science:

  • Altitude sickness research
  • Pharmacology of mountain sickness

Background:

  • Acute mountain sickness (AMS) presents with symptoms like headache, nausea, and weakness.
  • Acetazolamide is a commonly used prophylactic agent for AMS.
  • Dexamethasone also shows prophylactic benefits, potentially due to euphoric effects.

Purpose of the Study:

  • To review the prophylactic and therapeutic applications of Acetazolamide for acute mountain sickness.
  • To assess the evidence for Acetazolamide's effectiveness in severe forms of AMS.
  • To identify gaps in current research regarding AMS pharmacotherapy.

Main Methods:

  • Literature review of studies on Acetazolamide for AMS.
  • Analysis of evidence regarding Acetazolamide's impact on physiological markers of AMS.

Related Experiment Videos

  • Examination of data on alternative treatments and drug combinations.

    • Main Results:

    • Acetazolamide significantly reduces common AMS symptoms and improves objective measures.
    • Evidence for Acetazolamide's benefit in severe AMS (pulmonary/cerebral edema) is limited.
    • Large doses of Acetazolamide can improve symptoms by increasing arterial oxygen, but faster agents may be preferred in emergencies.

    Conclusions:

    • Acetazolamide is a valuable prophylactic for mild AMS, improving oxygenation and reducing symptoms.
    • Further research is needed to compare Acetazolamide with other treatments like steroids and calcium channel blockers.
    • The potential benefits of drug combinations for AMS warrant investigation.